Primary Record
cefroxadine
- In stock
- 9,263 g
- Purity
- 98.2 %
- CAS
- 51762-05-1
Compound Identifiers & Properties
- CAS
- 51762-05-1
- PubChem CID
- 5284529
- SMILES
- COC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O
- Canonical SMILES
- COC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1
Names & Synonyms
- cefroxadine
- Oraspor
- Cefroxadin
- Cefroxadinum
- Cefroxadino
- Cefthan-DS
- cefroxadina
- Cefthan
- Cgp 9000
- Cefthan-DS (TN)
- Cefroxadine (USAN)
- antibioticcgp9000
- CGP-9000
- Antibiotic CGP 9000
- AC1NR4MM
- Cefroxadinum [INN-Latin]
- Cefroxadino [INN-Spanish]
- Antibiotic CGP-9000
- CEFROXADINE [MI]
- 51762-05-1
- RefChem:124252
- B908C4MV2R
- CEFROXADINE [INN]
- UNII-B908C4MV2R
- DSSTox_CID_2768
- CEFROXADINE [USAN]
- DTXSID1022768
- SureCN147239
- Cefroxadine [USAN:INN:JAN]
- DTXCID602768
- CEFROXADINE [MART.]
- DSSTox_RID_76723
- CEFROXADINE [WHO-DD]
- CHEBI:31379
- SCHEMBL147239
- orb1705048
- CHEMBL3186538
- EINECS 257-391-8
- GTPL13619
- 51762-05-1 (free)
- J01DA35
- RDMOROXKXONCAL-UEKVPHQBSA-N
- ZINC3830462
- BRN 0587499
- Tox21_113142
- BBF-00741
- BBF-02762
- C16-H19-N3-O5-S
- AKOS040744851
- CID5284529
- DB11367
- J3.191G
- NCGC00185745-01
- DA-51754
- CAS-51762-05-1
- HY-107064
- CS-0027250
- NS00011580
- C12979
- D01528
- 762C051
- Q5057294
- CXD
- (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)-3-methoxy-3-cephem-4-carboxylic acid
- 7-(D-2-amino-2-(1,4-cyclohexadienyl)acetamido)-3-methoxy-3-cephem-4-carboxylic acid
- (6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methoxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- (6R,7R)-7-((R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido)-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-{[(2R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetyl]amino}-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 7-beta-[D-2-amino-2-(1,4-cyclohexadienyl)acetamido]-3-methoxy-3-cephem-4-carboxylic acid
- (6R,7R)-7-(((2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl)amino)-3-methoxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[(2R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[(R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[(2R)-2-Amino-2-(1-cyclohexa-1,4-dienyl)acetyl]amino]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[(R)-Amino(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 257-391-8
- 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methoxy-8-oxo-, (6R-(6 alpha,7 beta(R*)))-
- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((AMINO-1,4-CYCLOHEXADIEN-1-YLACETYL)AMINO)-3-METHOXY-8-OXO-, (6R-(6A,7B(R*)))-
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methoxy-8-oxo-, (6R-(6alpha,7beta(R*)))-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methoxy-8-oxo-,(6R,7R)-
- 7-{[(2R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetyl]amino}-3-methoxy-3,4-didehydrocepham-4-carboxylic acid